|
The Effects of Chin Tuck Against Resistance Exercise on Acute Stroke Patients With Dysphagia
RECRUITINGN/ASponsored by National Taiwan University Hospital
Actively Recruiting
PhaseN/A
SponsorNational Taiwan University Hospital
Started2024-12-22
Est. completion2026-10
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06674356
Summary
The aim of this study is to investigate the effects of chin tuck against resistance exercise on swallowing function, depression, and quality of life in acute stroke patients with dysphagia.
Eligibility
Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Patients diagnosed with hemorrhagic or ischemic stroke, including those with initial diagnoses or recurrent strokes. 2. Patients who did not pass the swallowing screening based on the standard swallowing scale. 3. Adults aged 18 years and older. 4. Vital signs are stable: systolic blood pressure (hemorrhagic \< 160 mmHg, ischemic \< 220 mmHg), heart rate 40-130 beats per minute, and oxygen saturation \> 92%. 5. The patient's consciousness is clear, able to express themselves, can communicate in Mandarin or Taiwanese, and can follow commands to perform actions. 6. The patient can be in a seated position. Exclusion Criteria: 1. Patients who have had a stroke for more than one month (inclusive). 2. Patients with a history of depression or related mental health disorders. 3. Patients with a history of neck pain, injury, or disease. 4. Patients who have previously undergone tracheostomy or have a tracheostomy tube in place.
Conditions3
Acute StrokeDepressionDysphagia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNational Taiwan University Hospital
Started2024-12-22
Est. completion2026-10
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06674356